AAAAAA

   
Results: 1-16 |
Results: 16
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptorsubtypes 5 and/or 3 in experimental pancreatic cancers
Authors: Szepeshazi, K Schally, AV Halmos, G Sun, BD Hebert, F Csernus, B Nagy, A
Citation: K. Szepeshazi et al., Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptorsubtypes 5 and/or 3 in experimental pancreatic cancers, CLIN CANC R, 7(9), 2001, pp. 2854-2861
Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness
Authors: Arencibia, JM Schally, AV Krupa, M Bajo, AM Nagy, A Szepeshazi, K Plonowski, A
Citation: Jm. Arencibia et al., Targeting of doxorubicin to ES-2 human ovarian cancers in nude mice by linking to an analog of luteinizing hormone-releasing hormone improves its effectiveness, INT J ONCOL, 19(3), 2001, pp. 571-577
A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice
Authors: Kiaris, H Schally, AV Nagy, A Szepeshazi, K Hebert, F Halmos, G
Citation: H. Kiaris et al., A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice, EUR J CANC, 37(5), 2001, pp. 620-628
Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix
Authors: Chatzistamou, I Schally, AV Szepeshazi, K Groot, K Hebert, F Arencibia, JM
Citation: I. Chatzistamou et al., Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix, CANCER LETT, 171(1), 2001, pp. 37-45
Hypothalamic hormones and cancer
Authors: Schally, AV Comaru-Schally, AM Nagy, A Kovacs, M Szepeshazi, K Plonowski, A Varga, JL Halmos, G
Citation: Av. Schally et al., Hypothalamic hormones and cancer, FRONT NEURO, 22(4), 2001, pp. 248-291
Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth
Authors: Szepeshazi, K Schally, AV Armatis, P Groot, K Hebert, F Feil, A Varga, JL Halmos, G
Citation: K. Szepeshazi et al., Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth, ENDOCRINOL, 142(10), 2001, pp. 4371-4378
Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238
Authors: Kiaris, H Schally, AV Nagy, A Sun, BD Szepeshazi, K Halmos, G
Citation: H. Kiaris et al., Regression of U-87 MG human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238, CLIN CANC R, 6(2), 2000, pp. 709-717
Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207
Authors: Chatzistamou, I Schally, AV Nagy, A Armatis, P Szepeshazi, K Halmos, G
Citation: I. Chatzistamou et al., Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207, CLIN CANC R, 6(10), 2000, pp. 4158-4165
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours
Authors: Szepeshazi, K Schally, AV Groot, K Armatis, P Hebert, F Halmos, G
Citation: K. Szepeshazi et al., Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours, EUR J CANC, 36(1), 2000, pp. 128-136
Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-junand c-fos oncogene expression by bombesin antagonists
Authors: Chatzistamou, I Schally, AV Sun, B Armatis, P Szepeshazi, K
Citation: I. Chatzistamou et al., Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-junand c-fos oncogene expression by bombesin antagonists, BR J CANC, 83(7), 2000, pp. 906-913
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers
Authors: Szepeshazi, K Schally, AV Groot, K Armatis, P Halmos, G Hebert, F Szende, B Varga, JL Zarandi, M
Citation: K. Szepeshazi et al., Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers, BR J CANC, 82(10), 2000, pp. 1724-1731
Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs
Authors: Szepeshazi, K Halmos, G Schally, AV Arencibia, JM Groot, K Vadillo-Buenfil, M Rodriguez-Martin, E
Citation: K. Szepeshazi et al., Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs, J CANC RES, 125(8-9), 1999, pp. 444-452
Effective treatment of advanced estrogen-independent MXT mouse mammary cancers with targeted cytotoxic LH-RH analogs
Authors: Szepeshazi, K Schally, AV Nagy, A
Citation: K. Szepeshazi et al., Effective treatment of advanced estrogen-independent MXT mouse mammary cancers with targeted cytotoxic LH-RH analogs, BREAST CANC, 56(3), 1999, pp. 267-276
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238
Authors: Plonowski, A Schally, AV Nagy, A Sun, BD Szepeshazi, K
Citation: A. Plonowski et al., Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238, CANCER RES, 59(8), 1999, pp. 1947-1953
Targeted cytotoxic analogue of bombesin/gastrin releasing peptide inhibitsthe growth of H-69 human small-cell lung carcinoma in nude mice
Authors: Kiaris, H Schally, AV Nagy, A Sun, B Armatis, P Szepeshazi, K
Citation: H. Kiaris et al., Targeted cytotoxic analogue of bombesin/gastrin releasing peptide inhibitsthe growth of H-69 human small-cell lung carcinoma in nude mice, BR J CANC, 81(6), 1999, pp. 966-971
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice
Authors: Miyazaki, M Schally, AV Nagy, A Lamharzi, N Halmos, G Szepeshazi, K Armatis, P
Citation: M. Miyazaki et al., Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice, AM J OBST G, 180(5), 1999, pp. 1095-1103
Risultati: 1-16 |